These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

846 related items for PubMed ID: 8751516

  • 1. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 2. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED.
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [Abstract] [Full Text] [Related]

  • 3. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC, Ziats N, Rao AK, Gikakis N, Sun L, Khan MM, Stenach N, Sapatnekar S, Chouhan V, Gorman JH, Niewiarowski S, Colman RW, Anderson JM, Edmunds LH.
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [Abstract] [Full Text] [Related]

  • 4. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumoto H, Yagi Y, Kawazoe K.
    ASAIO J; 1996 Jan; 42(4):301-5. PubMed ID: 8828788
    [Abstract] [Full Text] [Related]

  • 5. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R.
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [Abstract] [Full Text] [Related]

  • 6. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M, Demircin M, Guvener M, Peker O, Yilmaz M.
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [Abstract] [Full Text] [Related]

  • 7. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H, Baufreton C, Jansen PG, Thijs CM, Hack CE, Sturk A, Wildevuur CR, Loisance DY.
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations.
    McCarthy PM, Yared JP, Foster RC, Ogella DA, Borsh JA, Cosgrove DM.
    Ann Thorac Surg; 1999 May; 67(5):1268-73. PubMed ID: 10355394
    [Abstract] [Full Text] [Related]

  • 12. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E, Am Holen E, Tangen G, Ringdal MA.
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [Abstract] [Full Text] [Related]

  • 13. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [Abstract] [Full Text] [Related]

  • 14. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M, Oystese R.
    Eur J Cardiothorac Surg; 1996 Mar; 10(6):449-55. PubMed ID: 8817142
    [Abstract] [Full Text] [Related]

  • 15. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O, Fosse E, Dregelid E, Brockmeier V, Andersson C, Høgåsen K, Venge P, Mollnes TE, Kierulf P.
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [Abstract] [Full Text] [Related]

  • 16. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
    Suehiro S, Shibata T, Sasaki Y, Hattori K, Kumano H, Hosono M, Kinoshita H.
    Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN, Videm V, Baksaas ST, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [Abstract] [Full Text] [Related]

  • 18. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [Abstract] [Full Text] [Related]

  • 19. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J, Bagge L, Saldeen T, Thelin S.
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V, Kalaycioglu S, Gunaydin S, Imren Y, Gokgoz L, Soncul H, Ersoz A.
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.